EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease

Ryota Uehara iD, Eijiro Yamada iD, Shuichi Okada iD, Claire C Bastie, Akito Maeshima, Hidekazu Ikeuchi iD, Kazuhiko Horiguchi, Masanobu Yamada

Cells · 2023

DOI: 10.3390/cells12081197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Ryota Uehara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, 3-39-15, Showa, Maebashi 371…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagy is involved in the development of diabetic kidney disease (DKD), the leading cause of end-stage renal disease. The Fyn tyrosine kinase (Fyn) suppresses autophagy in the muscle. However, its role in kidney autophagic processes is unclear. Here, we examined the role of Fyn kinase in autophagy in proximal renal tubules both in vivo and in vitro. Phospho-proteomic analysis revealed that transglutaminase 2 (Tgm2), a protein involved in the degradation of p53 in the autophagosome, is phosphorylated on tyrosine 369 (Y369) by Fyn. Interestingly, we found that Fyn-dependent phosphorylation of Tgm2 regulates autophagy in proximal renal tubules in vitro, and that p53 expression is decreased upon autophagy in Tgm2-knockdown proximal renal tubule cell models. Using streptozocin (STZ)-induced hyperglycemic mice, we confirmed that Fyn regulated autophagy and mediated p53 expression via Tgm2. Taken together, these data provide a molecular basis for the role of the Fyn–Tgm2–p53 axis in the development of DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesDiabetes MellitusMiceAnimalsProtein Glutamine gamma Glutamyltransferase 2Tumor Suppressor Protein p53ProteomicsAutophagy

Stichwörter der Autor:innen

autophagydiabeticend-stage renal diseasehyperglycemiakidney

Substanzen

Protein Glutamine gamma Glutamyltransferase 2Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, 3-39-15, Showa, Maebashi 371-8511, Japan.
  • Division of Biomedical Sciences, Warwick Medical School, Coventry CV4 7AL, UK.
  • Department of Nephrology and Hypertension, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe 350-1298, Japan.
  • Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.

ORCID-Profile: Ryota Uehara, Eijiro Yamada, Shuichi Okada, Hidekazu Ikeuchi

Förderung

  • KAKENHI

Zitieren

APA

Uehara, R., Yamada, E., Okada, S., Bastie, C. C., Maeshima, A., Ikeuchi, H., Horiguchi, K., & Yamada, M. (2023). Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease. Cells. https://doi.org/10.3390/cells12081197

Vancouver

Uehara R, Yamada E, Okada S, Bastie CC, Maeshima A, Ikeuchi H, et al. Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease. Cells. 2023. doi:10.3390/cells12081197

BibTeX
@article{Uehara2023,
  author = {Uehara, Ryota and Yamada, Eijiro and Okada, Shuichi and Bastie, Claire C and Maeshima, Akito and Ikeuchi, Hidekazu and Horiguchi, Kazuhiko and Yamada, Masanobu},
  title = {Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12081197}
}
Kostenlos starten →